Yichang Humanwell Pharmaceutical Co., Ltd
http://en.ycrenfu.com.cn
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Yichang Humanwell Pharmaceutical Co., Ltd
On A Roll? EU Could Follow US, China & Japan In Approving Remimazolam
Paion’s novel sedation drug, remimazolam, was approved in the US, China, and Japan this year and now the European Medicines Agency is set to decide whether it should be authorized for use across the EU.
Company Information
- Industry
-
Pharmaceuticals
- Specialty Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice